71 related articles for article (PubMed ID: 38641834)
21. Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients.
Baert T; Van Camp J; Vanbrabant L; Busschaert P; Laenen A; Han S; Van Nieuwenhuysen E; Vergote I; Coosemans A
Gynecol Oncol; 2018 Jul; 150(1):31-37. PubMed ID: 29751991
[TBL] [Abstract][Full Text] [Related]
22. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Zhang W; Wang L; Xin Z
Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
[TBL] [Abstract][Full Text] [Related]
23. Total Infragastric Omentectomy Including the Vascular Perigastric Arcade in Patients With Advanced Serous Ovarian Tumors.
Cordeiro Vidal G; Croce S; Guyon F; Babin G; Querleu D
Int J Gynecol Cancer; 2017 Feb; 27(2):252-257. PubMed ID: 28114233
[TBL] [Abstract][Full Text] [Related]
24. Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Rose PG; Java JJ; Morgan MA; Alvarez-Secord A; Kesterson JP; Stehman FB; Warshal DP; Creasman WT; Hanjani P; Morris RT; Copeland LJ
Gynecol Oncol; 2016 Dec; 143(3):511-515. PubMed ID: 27692669
[TBL] [Abstract][Full Text] [Related]
25. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.
Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L
Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857
[TBL] [Abstract][Full Text] [Related]
26. Optimal sampling of grossly normal omentum in staging of gynecologic malignancies.
Skala SL; Hagemann IS
Int J Gynecol Pathol; 2015 May; 34(3):281-7. PubMed ID: 25760907
[TBL] [Abstract][Full Text] [Related]
27. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
McNally L; Teng NN; Kapp DS; Karam A
Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
[TBL] [Abstract][Full Text] [Related]
28. A framework for a personalized surgical approach to ovarian cancer.
Nick AM; Coleman RL; Ramirez PT; Sood AK
Nat Rev Clin Oncol; 2015 Apr; 12(4):239-45. PubMed ID: 25707631
[TBL] [Abstract][Full Text] [Related]
29. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Horowitz NS; Miller A; Rungruang B; Richard SD; Rodriguez N; Bookman MA; Hamilton CA; Krivak TC; Maxwell GL
J Clin Oncol; 2015 Mar; 33(8):937-43. PubMed ID: 25667285
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells.
Salimian Rizi B; Caneba C; Nowicka A; Nabiyar AW; Liu X; Chen K; Klopp A; Nagrath D
Cancer Res; 2015 Jan; 75(2):456-71. PubMed ID: 25425006
[TBL] [Abstract][Full Text] [Related]
31. The role of cytoreductive surgery in advanced ovarian cancer: the general surgeon's perspective.
Romanidis K; Nagorni EA; Halkia E; Pitiakoudis M
J BUON; 2014; 19(3):598-604. PubMed ID: 25261641
[TBL] [Abstract][Full Text] [Related]
32. Hematogenous metastasis of ovarian cancer: rethinking mode of spread.
Pradeep S; Kim SW; Wu SY; Nishimura M; Chaluvally-Raghavan P; Miyake T; Pecot CV; Kim SJ; Choi HJ; Bischoff FZ; Mayer JA; Huang L; Nick AM; Hall CS; Rodriguez-Aguayo C; Zand B; Dalton HJ; Arumugam T; Lee HJ; Han HD; Cho MS; Rupaimoole R; Mangala LS; Sehgal V; Oh SC; Liu J; Lee JS; Coleman RL; Ram P; Lopez-Berestein G; Fidler IJ; Sood AK
Cancer Cell; 2014 Jul; 26(1):77-91. PubMed ID: 25026212
[TBL] [Abstract][Full Text] [Related]
33. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer.
Lee JY; Kim HS; Chung HH; Kim JW; Park NH; Song YS
Ann Surg Oncol; 2014 Aug; 21(8):2762-6. PubMed ID: 24770785
[TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer.
Jayson GC; Kohn EC; Kitchener HC; Ledermann JA
Lancet; 2014 Oct; 384(9951):1376-88. PubMed ID: 24767708
[TBL] [Abstract][Full Text] [Related]
35. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.
Nowicka A; Marini FC; Solley TN; Elizondo PB; Zhang Y; Sharp HJ; Broaddus R; Kolonin M; Mok SC; Thompson MS; Woodward WA; Lu K; Salimian B; Nagrath D; Klopp AH
PLoS One; 2013; 8(12):e81859. PubMed ID: 24312594
[TBL] [Abstract][Full Text] [Related]
36. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer.
Arie AB; McNally L; Kapp DS; Teng NN
Gynecol Oncol; 2013 Dec; 131(3):784-90. PubMed ID: 24056005
[TBL] [Abstract][Full Text] [Related]
37. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy.
Ben Arie A; McNally L; Kapp DS; Teng NN
Gynecol Oncol; 2013 Dec; 131(3):780-3. PubMed ID: 24056004
[TBL] [Abstract][Full Text] [Related]
38. Advanced ovarian cancer: omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor.
Raspagliesi F; Ditto A; Martinelli F; Haeusler E; Lorusso D
Gynecol Oncol; 2013 Apr; 129(1):92-6. PubMed ID: 23385151
[TBL] [Abstract][Full Text] [Related]
39. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Nieman KM; Kenny HA; Penicka CV; Ladanyi A; Buell-Gutbrod R; Zillhardt MR; Romero IL; Carey MS; Mills GB; Hotamisligil GS; Yamada SD; Peter ME; Gwin K; Lengyel E
Nat Med; 2011 Oct; 17(11):1498-503. PubMed ID: 22037646
[TBL] [Abstract][Full Text] [Related]
40. The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer.
Shroff R; Brooks RA; Zighelboim I; Powell MA; Thaker PH; Mutch DG; Massad LS
Int J Gynecol Cancer; 2011 Oct; 21(7):1208-12. PubMed ID: 21633295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]